New dissolving stent could spare kids repeated heart surgeries
NCT ID NCT07628101
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This trial tests a new type of stent that dissolves over time for children under 9 with narrowed arteries in or near the heart. The stent opens the vessel and then gradually disappears, allowing the artery to grow naturally. The study will enroll 45 children and follow them for 5 years to see if the stent is safe and works better than permanent stents.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- CardiaZn bioresorbable stent (zinc-silver alloy)
- What this could lead to
- If it works, this could provide a one-time treatment for narrowed arteries in children, avoiding repeated surgeries and allowing vessels to grow naturally.
- What could go wrong
- This is an early pivotal trial with only 45 children, so results may not apply to all. Risks include vessel damage, stent clotting, or the stent not dissolving as planned.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC COARCTATION, PULMONARY ARTERY STENOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.